Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
MSM vs Omega-3: Omega-3 has the stronger overall evidence (9 vs 6/10); they're alternatives for inflammation-related symptoms — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Omega-3 wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Probably helps
10 of 15 studies with measurable effects showed benefit.
Top outcomes
2-3g
With meals, Split into 2-3 doses
Powder or capsules
2-3g combined EPA+DHA daily (a typical label dose, not the dose used in the cited trials, which gave 1 g or 3.25 g of omega-3 a day, or 1 to 4 g of fish oil a day without stating its EPA+DHA content)
With meals containing fat
Triglyceride form fish oil
4-12 weeks
2-4 weeks
8-12 weeks
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Effects of dietary supplements on patients with osteoarthritis: A systematic review and network meta-analysis
Journal of integrative medicine (2025) · Meta analysis · n=2455
In the WOMAC pain score, the SUCRA of passion fruit peel extract was 91% (mean difference [MD]: -9.2; 95% confidence interval [CI]: [-16.0, -2.3]), followed by methylsulfonylmethane (89%), undenatured type II collagen (87%), collagen (84%), and Lanconone (82%).
Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients (2023) · Rct · n=88
The total scores at 12 weeks in the MSM and placebo groups as the primary outcome were significantly different (p = 0.046).
The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized Controlled Trial
Nutrients (2021) · Rct · n=22
The primary finding of this work shows that high-density lipoprotein cholesterol was elevated at 8 and 16 weeks of daily MSM consumption compared to baseline, (p = 0.008, p = 0.013).
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
12 RCTs with 587 subjects: omega-3 supplementation increased serum BDNF versus placebo (SMD 0.72, 95% CI 0.28 to 1.15), with high heterogeneity (I2 = 84.39%).
The two points come from two separate placebo-controlled trials, not from one trial comparing doses. At 2,000 mg a day (ten 200 mg tablets) for 12 weeks, 88 Japanese adults with mild knee pain improved their total knee score more than placebo (PMID 37447322, p = 0.046). At 6,000 mg a day (3 g twice daily) for 12 weeks, 50 adults with knee osteoarthritis had less WOMAC pain and better physical function than placebo, with no change in stiffness or total symptoms and no major adverse events (PMID 16309928). The populations and scales differ, so the curve is drawn flat: the trials cannot show whether 6 g works better than 2 g. A 16-week trial at 6 g a day found no difference from placebo in blood counts, liver and kidney markers, weight or blood pressure (PMID 31331587). No optimal dose has been established.
The points are the dose bands of a meta-analysis of 10 randomised trials with 1,426 adults (PMID 37028202): EPA-rich products at 1 to under 2 g of EPA a day reduced depression severity (SMD -0.43), while 2 g a day or more did not (SMD -0.20, not significant), so the 2 g point is plotted as no effect. Doses are grams of EPA, not EPA plus DHA. The Cochrane review of 33 placebo-controlled trials found a small to modest effect, unlikely to be clinically meaningful and rated very low certainty, with no difference in remission or response (PMID 34817851). No trial compared doses directly.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 6/10) and wins in 2 of 3 categories.
For inflammation-related symptoms, Omega-3 has a higher relevance score (85 vs 40).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Curcumin, omega-3, UC-II collagen, Boswellia vs the old glucosamine default — and OA vs RA.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Which supplements clash with blood thinners, thyroid meds, antibiotics & more — and what to do.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.